Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer
β Scribed by Steven D Trocha; Armando E Giuliano
- Book ID
- 113922056
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 205 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0960-7404
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were
## Abstract Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence supports delivering chemotherapy in the neoadjuvant setting; the data shows improvement in progressionβfree and overall